Interaction of curcumin on cisplatin cytotoxicity in HeLa and HepG2 carcinoma cells

Merve BECİT; Sevtap AYDIN DİLSİZ; Nurşen BAŞARAN

Makale detayları

Interaction of curcumin on cisplatin cytotoxicity in HeLa and HepG2 carcinoma cells

Yazarlar:

Merve BECİT | Sevtap AYDIN DİLSİZ | Nurşen BAŞARAN

Yayıncı:

Istanbul University

Ana Başlıklar:

Farmakoloji ve terapötik | Sağlık teşvikleri

Dergi:

İstanbul Journal of Pharmacy 2020 Vol.50 Issue 3, pp.202-210

Belge Tipi:

Makale

Yayın Tarihi:

12/2020

Belge Dili:

İngilizce

Document ID (Org No.):

2000512918

Sıklık:

Aylık

eISSN:

2587-2087

Özet:

 

Background and Aims: Our study aimed to evaluate how curcumin affect cisplatin cytotoxicity in human cervical carcinoma (HeLa), human hepatocellular carcinoma (HepG2), and Chinese hamster lung fibroblast (V79) cells. Methods: The cytotoxicity was evaluated by MTT assay. Results: The IC50 values of curcumin were 404 μM and 320 μM in HeLa cells; 236 μM and 98.3 μM in HepG2 cells; 877 μM and 119 μM in V79 cells; for 24 h and 48 h, respectively. The IC50 values of cisplatin were 22.4 μM and 12.3 μM in HeLa cells; 25.5 μM and 7.7 μM in HepG2 cells; 15.4 μM and 4.9 μM in V79 cells; for 24 h and 48 h, respectively. Curcumin significantly decreased cisplatin cytotoxicity at 500 μM in HeLa cells and above 250 μM and 125 μM in HepG2 cells, for 24 h and 48 h, respectively. In V79 cells, curcumin significantly decreased the IC50 values of cisplatin above 500 μM and 125 μM for 24 h and 48 h. Conclusion: The results might contribute to the anticancer effect of the curcumin-cisplatin combination in cervical and hepatocellular carcinoma, but in order to support this result and determine its interactions with antineoplastic drugs, further studies are needed.

Makale detayları

Interaction of curcumin on cisplatin cytotoxicity in HeLa and HepG2 carcinoma cells

Yazarlar: Merve BECİT | Sevtap AYDIN DİLSİZ | Nurşen BAŞARAN

Yayıncı: Istanbul University

Ana Başlıklar: Farmakoloji ve terapötik | Sağlık teşvikleri

Dergi: İstanbul Journal of Pharmacy 2020 Vol.50 Issue 3, pp.202-210

Belge Tipi: Makale

Yayın Tarihi: 12/2020

Belge Dili: İngilizce

Document ID (Org No.): 2000512918

Sıklık: Aylık

eISSN: 2587-2087

Sayı

Yazarlar:

Merve BECİT | Sevtap AYDIN DİLSİZ | Nurşen BAŞARAN

Yayıncı:

Istanbul University

Ana Başlıklar:

Farmakoloji ve terapötik | Sağlık teşvikleri

Dergi:

İstanbul Journal of Pharmacy 2020 Vol.50 Issue 3, pp.202-210

Belge Tipi:

Makale

Yayın Tarihi:

12/2020

Belge Dili:

İngilizce

Document ID (Org No.):

2000512918

Sıklık:

Aylık

eISSN:

2587-2087